Zhang Z M, Yu Y T
Chaoyang No.2 Hospital, Liaoning.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1992 Oct;12(10):598-601, 580.
A prospective controlled study on the treatment of 60 cases chronic gastritis with TCM Yingwei tablet as well as Sucrafati and Doperidone tablets from Oct. 1990 to Sep. 1991 were done. 30 patients in each group. The cases in treated group took Yingwei tablet while that in control group took Sucrafati and Doperidone tablets. Before and after treatment, the patients were examined by gastroscope, pathology and Helicobacter pylori. The results showed that total effective rate, the gastroscopically effective rate, the pathological cure rate, the cure rate of gastric mucosa atrophy and the effective rate of bacteriocidal effect against Helicobacter pylori in treated group and control group was 96.7% and 73.3%; 80% and 70%; 36.7% and 20%; 38% and 9%; 60% and 23.0%, respectively, all of the above-mentioned differences between the two groups was significant (P < 0.05-0.01). Therefore Yingwei tablet is an effective drug for various kind of chronic gastritis.
1990年10月至1991年9月，采用中药应维片以及硫糖铝和多潘立酮片对60例慢性胃炎患者进行了前瞻性对照研究。每组30例患者。治疗组患者服用应维片，对照组患者服用硫糖铝和多潘立酮片。治疗前后，对患者进行胃镜、病理及幽门螺杆菌检查。结果显示，治疗组和对照组的总有效率、胃镜有效率、病理治愈率、胃黏膜萎缩治愈率及幽门螺杆菌杀菌有效率分别为96.7%和73.3%；80%和70%；36.7%和20%；38%和9%；60%和23.0%，两组上述各项差异均有统计学意义（P<0.05 - 0.01）。因此，应维片是治疗各种慢性胃炎的有效药物。
